Rob Coker - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Rob Coker's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Rob Coker
Verified
Editorial Content Producer, Interplas Insights
Beats
politics., television feminism, male violence against womenWomen’s rights, literature film
Anything non-financial
Content
By Rob Coker| The Medicine Maker Verified As US president Donald Trump continues to impose his various agendas, we summarize the latest news and how it affects the manufacturing, distribution, and consumption of pharmaceuticals. Trump has initiated Section 232 investigations into pharmaceutical and semiconductor imports, citing national security concerns over US reliance on foreign production. Announced on April 14, analysts are preparing for 10-25 percent tariffs by mid-May.
By Rob Coker| The Medicine Maker Verified As US president Donald Trump continues to impose his various agendas, we summarize the latest news and how it affects the manufacturing, distribution, and consumption of pharmaceuticals. Trump has initiated Section 232 investigations into pharmaceutical and semiconductor imports, citing national security concerns over US reliance on foreign production. Announced on April 14, analysts are preparing for 10-25 percent tariffs by mid-May.
By Rob Coker| The Medicine Maker Verified Antibody-drug conjugates (ADCs) have long since promised to become the smart weapon of oncology by combining the specificity of antibodies with the potency of small molecule drugs. After decades of slow and steady progress, is the field finally hitting the accelerator? New advances in drug-to-antibody ratio (DAR), multispecific targeting, and nontraditional payloads could rewrite the ADC playbook, while simultaneously surfacing new scientific, manufacturing, and commercial challenges.
Company Info
Interplas Insights
Interplas Insights is an integral part of the Interplas event, the UK's leading trade show for the plastics industry. Managed by Rapid News Group since 2010, Interplas Insights serves as a knowledge hub that complements the trade show by providing expert content on trends in the plastics sector, including sustainability and digitalization. The platform features a comprehensive conference program with presentations, panel discussions, and insights on critical themes in plastics manufacturing. Topics covered include new materials, automation, and software solutions. The Interplas event attracts over 12,000 attendees, primarily from the UK manufacturing community, and showcases more than 500 exhibitors presenting innovations in plastics technology. Interplas Insights enhances the experience by facilitating networking and knowledge sharing among industry professionals, engineers, and business leaders.
United Kingdom, United Kingdom
+49 211 4560
Founded: 1998